Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic outcomes from the PARTNER 3 low-risk randomized trial.The goal of PARTNER 3 was to evaluate transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (SAVR) among low-risk patients with symptomatic severe aortic stenosis.
Filmed remotely from Texas.
Музыка
Фильмы
ТВ Шоу
Категории видео
